The Ministry of Health and Medical Services is in the process of implementing rapid antigen testing for HIV in specific populations and locations. Dr. Rachel Devi, head of Family Health, stated that the current testing method in Fiji relies on antibody testing.
She explained the point-of-care testing process, which allows individuals to receive quick results after providing a blood sample at a clinic. “During a visit to a clinic, patients can undergo point-of-care testing, where a blood sample is taken and analyzed on-site, with results available in about 20 minutes,” she elaborated. Currently, sexual reproductive health centers offer this service, and the ministry aims to expand point-of-care testing for confirmation purposes.
Dr. Devi noted that the ministry has yet to investigate the feasibility of at-home rapid antigen self-testing for individuals hesitant to seek testing at medical facilities. She emphasized the importance of addressing potential psychological implications and the need for education before introducing self-testing options.
“The ministry’s focus is on ensuring effective testing and counseling for individuals,” she declared. Dr. Devi acknowledged the challenge many individuals face when receiving a positive HIV diagnosis, often leading to withdrawal from social interactions. Thus, counseling is considered critical for individuals receiving their test results.
As for antigen testing, she clarified that it will be administered by healthcare professionals rather than being self-administered. The ministry is also working towards decentralizing confirmation services for HIV diagnoses, allowing for more locations, including reproductive health clinics, to provide this service within two to three months.
Dr. Devi stated that individuals would be given a three-month timeline for follow-up testing, particularly if they have engaged in high-risk behaviors, such as unprotected sex or injectable drug use. Test results would help determine if an individual has been involved in unsafe practices, necessitating a repeat blood test to verify any possible new infections.